Laboratory Clinicians and Transfusion Medicine Specialist at the Center of Patient Safety

Program Chair(s)

• 

  Marisa Saint Martin, MD, ACC

  Affiliate Associate Professor
  Loyola University Medical Center, Florida, United States

  Disclosure(s): No financial relationships to disclose

  PDF

Speaker(s)

• KK

  Kimberly Klein, MD

  Medical Director of the Hemovigilance Unit
  M.D. Anderson Cancer Center
  Houston, Texas, United States

  Disclosure(s): No financial relationships to disclose

  PDF
• JK

  James Kelley, MD, PhD

  Chief Medical Officer
  OneOme
  Minneapolis, Minnesota, United States

  Disclosure(s): OneOme, LLC: Full-time/Part-time Employee or Owner (Ongoing)

  PDF

“First do no harm” has been the central dogma of practice of medicine since antiquity and continues to be the guiding principle today. Efforts have been made at local, national and international levels to ensure that patient safety is at the forefront of all aspects of clinical care. Although many of these efforts are led by clinical specialists, the laboratories including the blood bank had been an essential partner in providing objective data and metrics to measure, improve and monitor patient safety. In the past decade as clinical practice evolved, electronic-based medical records became an integral part of documenting and storing patient’s data. It presents opportunities for laboratorians including blood bankers to lead and be the catalyst for new patient safety initiatives. In this session, Dr. James Kelley will present discuss the importance of patient safety programs that were driven by laboratorians and how the use of laboratory results in conjunction with clinical data can improve patient safety. Dr. Kim Klein will share her institution’s first of its kind prospective monitoring programs which utilize state of the art technologies with novel deployment of nursing resources for early detection and prevention of severity transfusion reactions.